| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.87▲ | 6.85▲ | 6.87▲ | 7.05▼ | 6.29▲ |
| MA10 | 6.85▲ | 6.88▲ | 6.94▼ | 6.81▲ | 6.68▲ |
| MA20 | 6.83▲ | 7.02▼ | 7.09▼ | 6.27▲ | 6.77▲ |
| MA50 | 7.00▼ | 7.10▼ | 7.01▼ | 6.72▲ | 9.55▼ |
| MA100 | 7.13▼ | 6.93▼ | 6.54▲ | 6.83▲ | N/A |
| MA200 | 7.05▼ | 6.35▲ | 6.41▲ | 8.83▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | -0.019▼ | -0.046▼ | 0.129▲ | 0.165▲ |
| RSI | 50.764▲ | 44.402▼ | 46.242▼ | 56.097▲ | 45.910▼ |
| STOCH | 62.143 | 33.812 | 25.338 | 54.598 | 37.788 |
| WILL %R | -10.000▲ | -57.143 | -71.429 | -42.742 | -42.162 |
| CCI | 174.695▲ | -32.673 | -61.675 | 70.215 | 44.293 |
| MA | $ABVX Price Crossed Below MA(7) | Set Alert |
|
Tuesday, April 29, 2025 03:00 PM
The Phase 3 ABTECT trials (Studies 105 and 106) evaluating obefazimod in patients with moderately to severely active ulcerative colitis successfully enrolled 1,275 participants, exceeding the target ...
|
|
Tuesday, April 29, 2025 01:15 PM
StudyAbivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis 29.04.2025 / 22:05 CET/CESTThe issuer is solely ...
|
|
Tuesday, April 29, 2025 07:59 AM
We’ve spoken before, but as a refresher for our readers, can you talk a little bit about the company, including some major milestones? Mr. de Garidel: So, Abivax is a company that is primarily ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 7.23 | 7.83 | 6.70 | 6.91 | 100,216 |
| 30/04/25 | 7.51 | 7.51 | 7.00 | 7.12 | 102,608 |
| 29/04/25 | 7.09 | 7.41 | 7.06 | 7.11 | 45,325 |
| 28/04/25 | 7.095 | 7.41 | 6.9475 | 7.26 | 45,621 |
| 25/04/25 | 7.04 | 7.08 | 6.76 | 6.84 | 26,965 |
| 24/04/25 | 7.00 | 7.386 | 6.8201 | 6.93 | 105,214 |
| 23/04/25 | 6.79 | 7.97 | 6.75 | 6.765 | 230,909 |
| 22/04/25 | 6.17 | 6.605 | 6.17 | 6.50 | 104,398 |
| 21/04/25 | 6.57 | 6.75 | 6.165 | 6.23 | 15,695 |
| 17/04/25 | 6.09 | 6.63 | 5.98 | 6.40 | 125,307 |
|
|
||||
|
|
||||
|
|